• Proprietary AlloFresh™ preservation method retains viable cells, native ECM structure, growth factors, and cytokines

Affinity® is an allograft intended for use in the management of acute and chronic wounds as well as appropriate surgical applications. Affinity® may be applied as a wound covering to a variety of partial- and full-thickness acute and chronic wounds, and wounds with exposed tendon, muscle, joint capsule, and bone. Affinity® can be applied from the onset and for the duration of the wound, weekly, or at the discretion of the health care practitioner.

Affinity® is contraindicated for use on clinically infected wounds. Affinity® is contraindicated for use in surgical implantation sites with active or latent infection. Please refer to the Affinity® Instructions for Use for additional information.

As with all allogeneic materials, it is not possible to provide an absolute guarantee that no infectious disease will be transmitted. However, this risk is greatly reduced by using processing treatments shown to be capable of reducing this risk as well as the use of strict donor screening criteria, laboratory testing, aseptic processing, and microbiological culturing of final product. Single patient, single use only. Do not sterilize or re-sterilize. Do not use if expiration date has been exceeded.

Transmission of diseases of unknown etiology; transmission of known infectious agents including, such as viruses, bacteria and fungi; immune rejection of implanted HCT/P; loss of function and/or integrity of implanted HCT/P due to resorption, fragmentation and/or disintegration.

All fresh allografts must be maintained at refrigerated temperature (between 1°C and 10°C) during storage.